RECURSION PHARMACEUTICALS, INC. ($RXRX)
Filing Information
| Accession Number | 0001601830-26-000020 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 20, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
25,334
Total Value
$82,911.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Class A Common Stock | โ | Feb 17, 2026 | Tax Withholding | 11,908 | $3.49 | $41,558.92 | 1,208,775 | Direct | โ | View Details | |
Chief Financial Officer | Class A Common Stock | โ | Feb 18, 2026 | Sale | 13,426 | $3.08 | $41,352.08 | 1,195,349 | Direct | โ | View Details |